LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 75.19 | 27.76 | 4426 | 7015 | 0.6309 | 0.8879 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 75.19 | 27.76 | 4460 | 7015 | 0.6358 | 0.8897 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 75.19 | 27.76 | 6573 | 7015 | 0.9370 | 0.9838 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 75.19 | 27.76 | 6615 | 7015 | 0.9430 | 0.9853 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 76.89 | 27.76 | 4480 | 7025 | 0.6377 | 0.8904 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 76.89 | 27.76 | 4516 | 7025 | 0.6428 | 0.8923 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 76.89 | 27.76 | 6686 | 7025 | 0.9517 | 0.9876 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 76.89 | 27.76 | 6727 | 7025 | 0.9576 | 0.9892 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 78.60 | 27.76 | 4538 | 7045 | 0.6441 | 0.8928 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 78.60 | 27.76 | 4585 | 7045 | 0.6507 | 0.8953 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 78.60 | 27.76 | 6809 | 7045 | 0.9664 | 0.9915 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 78.60 | 27.76 | 6899 | 7045 | 0.9792 | 0.9947 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 80.31 | 27.76 | 4547 | 6976 | 0.6518 | 0.8955 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 80.31 | 27.76 | 4589 | 6976 | 0.6578 | 0.8977 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 80.31 | 27.76 | 6891 | 6976 | 0.9878 | 0.9969 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 80.31 | 27.76 | 6957 | 6976 | 0.9973 | 0.9993 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 82.01 | 27.76 | 4544 | 7000 | 0.6491 | 0.8946 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 82.01 | 27.76 | 4595 | 7000 | 0.6564 | 0.8972 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 82.01 | 27.76 | 7056 | 7000 | 1.0079 | 1.0020 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 82.01 | 27.76 | 7123 | 7000 | 1.0175 | 1.0044 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 83.72 | 27.76 | 4459 | 7055 | 0.6320 | 0.8884 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 83.72 | 27.76 | 4606 | 7055 | 0.6528 | 0.8960 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 83.72 | 27.76 | 7174 | 7055 | 1.0168 | 1.0042 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 83.72 | 27.76 | 7280 | 7055 | 1.0318 | 1.0079 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 85.42 | 27.76 | 4567 | 7025 | 0.6501 | 0.8950 | MN20160318_Q01 | C03 |